BIOMARIN PHARMACEUTICAL INC BMRN
BIOMARIN PHARMACEUTICAL INC institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 22,738,349 | $1.9B | 11.52% |
| DODGE & COX | 14,844,930 | $849.4M | 7.52% |
| VIKING GLOBAL INVESTORS LP | 7,616,563 | $435.8M | 3.86% |
| AQR CAPITAL MANAGEMENT LLC | 5,699,541 | $322.5M | 2.89% |
| MILLENNIUM MANAGEMENT LLC | 2,113,816 | $121.0M | 1.07% |
| CITADEL ADVISORS LLC | 1,403,008 | $80.3M | 0.71% |
| RENAISSANCE TECHNOLOGIES LLC | 451,871 | $25.9M | 0.23% |
| Bridgewater Associates, LP | 274,911 | $15.7M | 0.14% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.